. Pregnancy decision-making in women with multiple sclerosis treated with
natalizumab: I: Fetal risks: Pregnancy decision-making in women with multiple
sclerosis treated with natalizumab: II: Maternal risks. Neurology 2020 Mar 2. pii: WNL.0000000000008670.
PMID: 32123051